西南国防医药
西南國防醫藥
서남국방의약
MEDICAL JOURNAL OF NATIONAL DEFENDING FORCES IN SOUTHWEST CHINA
2014年
5期
483-486
,共4页
梁晓辉%赵子粼%罗建春%马利贤%覃善都%赵东海
樑曉輝%趙子粼%囉建春%馬利賢%覃善都%趙東海
량효휘%조자린%라건춘%마리현%담선도%조동해
间充质干细胞%心肌梗死%心力衰竭%细胞移植
間充質榦細胞%心肌梗死%心力衰竭%細胞移植
간충질간세포%심기경사%심력쇠갈%세포이식
mesenchymal stem cells%myocardial infarction%heart failure%cell transplantation
目的:观察华通胶间充质干细胞( WJ-MHCs)移植对心肌梗死后心力衰竭的疗效。方法选择解放军303医院74例心肌梗死后心力衰竭的患者随机分为治疗组(37例)与对照组(37例),对照组只进行常规药物治疗,治疗组在常规药物治疗的基础上进行WJ-MHCs移植。检测各组治疗前及治疗后2 w及第2个月外周血浆N末端B型利钠肽原(NT-proBNP)水平,用心脏超声检测左室心功能指标,并记录严重不良临床事件。结果治疗及随访期间两组临床不良事件发生率差异无统计学意义。治疗后第2 w及第2个月,两组NT-proBNP较术前均有改善,但治疗组较对照组改善更显著( P<0.05);治疗组治疗后第2个月LVEDV较治疗前显著减小(P<0.05),其余左室心功能指标变化差异无统计学意义,而对照组各项指标治疗前后变化无统计学意义。结论 WJ-MHCs移植治疗心肌梗死后心力衰竭安全有效,可以显著降低患者的NT-proBNP水平。
目的:觀察華通膠間充質榦細胞( WJ-MHCs)移植對心肌梗死後心力衰竭的療效。方法選擇解放軍303醫院74例心肌梗死後心力衰竭的患者隨機分為治療組(37例)與對照組(37例),對照組隻進行常規藥物治療,治療組在常規藥物治療的基礎上進行WJ-MHCs移植。檢測各組治療前及治療後2 w及第2箇月外週血漿N末耑B型利鈉肽原(NT-proBNP)水平,用心髒超聲檢測左室心功能指標,併記錄嚴重不良臨床事件。結果治療及隨訪期間兩組臨床不良事件髮生率差異無統計學意義。治療後第2 w及第2箇月,兩組NT-proBNP較術前均有改善,但治療組較對照組改善更顯著( P<0.05);治療組治療後第2箇月LVEDV較治療前顯著減小(P<0.05),其餘左室心功能指標變化差異無統計學意義,而對照組各項指標治療前後變化無統計學意義。結論 WJ-MHCs移植治療心肌梗死後心力衰竭安全有效,可以顯著降低患者的NT-proBNP水平。
목적:관찰화통효간충질간세포( WJ-MHCs)이식대심기경사후심력쇠갈적료효。방법선택해방군303의원74례심기경사후심력쇠갈적환자수궤분위치료조(37례)여대조조(37례),대조조지진행상규약물치료,치료조재상규약물치료적기출상진행WJ-MHCs이식。검측각조치료전급치료후2 w급제2개월외주혈장N말단B형리납태원(NT-proBNP)수평,용심장초성검측좌실심공능지표,병기록엄중불량림상사건。결과치료급수방기간량조림상불량사건발생솔차이무통계학의의。치료후제2 w급제2개월,량조NT-proBNP교술전균유개선,단치료조교대조조개선경현저( P<0.05);치료조치료후제2개월LVEDV교치료전현저감소(P<0.05),기여좌실심공능지표변화차이무통계학의의,이대조조각항지표치료전후변화무통계학의의。결론 WJ-MHCs이식치료심기경사후심력쇠갈안전유효,가이현저강저환자적NT-proBNP수평。
Objective To observe the therapeutic effects of human umbilical cord Wharton 's jelly mesenchymal stem cells ( WJ-MSC) transplantation on heart failure of acute myocardial infarction .Methods 74 cases with heart failure of acute myocardial infarction in Hospital 303 of PLA were randomly divided into 2 groups:treatment group and control group ,37 in each.Drug therapy was applied to patients in both groups ,while WJ-MHCs transplantation was added to patients in treatment group .The detections were made to plasma NT-proBNP in the peripheral blood before treatment ,2 weeks and 2 months after treatment;and left ventricular function was evaluated by ultrasound;the severe adverse clinical events were recorded .Results The occurrence of adverse clinical events in treatment and follow-up period in the 2 groups was of no statistical difference;NT-proBNP of the patients in both groups 2 weeks and 2 months after treatment was more improved than that before treatment ,while the improvement in treatment group was more obvious than that in control group (P<0.05);LVEDV in treatment group 2 months after treatment decreased much more than that before treatment (P<0.05),and the changes of other index of left ventricular function were of no statistical significance ;the index before and after treatment in control group were of no statistical changes .Conclusions WJ-MHCs transplantation is safe and effective in treating heart failure of acute myocardial infarction and can greatly decrease the level of NT-proBNP of the patients .